Citigroup Inc news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

C 47.62 +0.52 (1.10%)
price chart
SDL plc Cut to "Neutral" at Citigroup Inc. (SDL)
SDL plc (LON:SDL) was downgraded by equities research analysts at Citigroup Inc. to a �neutral� rating in a research note issued to investors on Thursday.
SDL plc Lowered to "Neutral" at Citigroup Inc. (SDL)  Mideast Time
Citigroup Inc Earnings: Profit Plunges Higher Legal Costs and Lower Trading ...
This morning, Citigroup (NYSE: C ) became of third big bank to miss profit targets for the fourth quarter of 2014 thanks to a large increase in legal expenses and lower revenue from trading.
Citigroup Too Cheap To Pass Up  Seeking Alpha
Citigroup Inc (NYSE:C) Trading Outlook  Live Trading News
Citigroup Trailblazer Flaherty to Retire
Pam Flaherty joined the bank that would become Citigroup Inc. in 1968, when the firm often didn't hire women for certain roles.
TravelCenters of America's "Buy" Rating Reaffirmed at Citigroup Inc. (TA)
TravelCenters of America LLC logo Citigroup Inc. reaffirmed their buy rating on shares of TravelCenters of America (NYSE:TA) in a report released on Thursday.
Citigroup Inc. Boosts Bank of New York Mellon Corp Price Target to $41.00 (BK)
Bank of New York Mellon Corp logo Bank of New York Mellon Corp (NYSE:BK) had its price objective raised by Citigroup Inc. from $40.00 to $41.00 in a research report released on Tuesday morning.
Bank of America Corp, Citigroup Inc, Wells Fargo & Co, JPMorgan Chase & Co ...
As of January 17, the group was already down 11% year to date, compared to a 3% drop in the S&P 500. The big four U.S. banks - Bank of America Corp.
Citigroup Inc. Downgrades Oneok Partners to Neutral (OKS)
Oneok Partners (NYSE:OKS) was downgraded by Citigroup Inc. from a �buy� rating to a �neutral� rating in a research note issued on Wednesday, TheFlyOnTheWall.
Citigroup Should Begin To Under-Promise And Over-Deliver (C)
Over-promising and under-delivering has plagued the company in the past and that's why it has remained stagnant for the past four years.
Citigroup: CCAR, QE And Notes From Fixed Income Call
Citi's CFO and Treasurer provided additional important disclosures relating to Citigroup's operations in the traditional fixed income call.
Calithera Biosciences Price Target Raised to $30.00 at Citigroup Inc. (CALA)
Calithera Biosciences (NASDAQ:CALA) had its target price lifted by Citigroup Inc. from $15.00 to $30.00 in a research note released on Wednesday morning.
Citigroup Inc. Boosts Calithera Biosciences Price Target to $30.00 (CALA)  sleekmoney
Citigroup Inc. Increases Calithera Biosciences Price Target to $30.00 (CALA)  Intercooler